key: cord-0794087-ia8abohy
authors: Dell’Oglio, Paolo; Cacciamani, Giovanni Enrico; Muttin, Fabio; Mirabella, Giuseppe; Secco, Silvia; Roscigno, Marco; Rovati, Federico Alessandro; Barbieri, Michele; Naspro, Richard; Peroni, Angelo; Saccà, Antonino; Pellucchi, Federico; Bocciardi, Aldo Massimo; Simeone, Claudio; Da Pozzo, Luigi; Galfano, Antonio
title: Applicability of COVID-19 Pandemic Recommendations for Urology Practice: Data from Three Major Italian Hot Spots (BreBeMi)
date: 2021-01-29
journal: Eur Urol Open Sci
DOI: 10.1016/j.euros.2021.01.012
sha: c835c32f4c93714178bd4758ae5f8d3dbafe8c2f
doc_id: 794087
cord_uid: ia8abohy

Background Lombardy has been the first and one of the most affected European regions during the first and second waves of the novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]). Objective To evaluate the impact of coronavirus disease 2019 (COVID-19) on all urologic activities over a 17-wk period in the three largest public hospitals in Lombardy located in the worst hit area in Italy, and to assess the applicability of the authorities’ recommendations provided for reorganising urology practice. Design, setting, and participants A retrospective analysis of all urologic activities performed at three major public hospitals in Lombardy (Brescia, Bergamo, and Milan), from January 1 to April 28, 2020, was performed. Outcome measurements and statistical analysis Join-point regression was used to identify significant changes in trends for all urologic activities. Average weekly percentage changes (AWPCs) were estimated to summarise linear trends. Uro-oncologic surgeries performed during the pandemic were tabulated and stratified according to the first preliminary recommendations by Stensland et al (Stensland KD, Morgan TM, Moinzadeh A, et al. Considerations in the triage of urologic surgeries during the COVID-19 pandemic. Eur Urol 2020;77:663–6) and according to the level of priority recommended by European Association of Urology guidelines. Results and limitations The trend for 2020 urologic activities decreased constantly from weeks 8–9 up to weeks 11–13 (AWPC range –41%, –29.9%; p < 0.001). One-third of uro-oncologic surgeries performed were treatments that could have been postponed, according to the preliminary urologic recommendations. High applicability to recommendations was observed for non–muscle-invasive bladder cancer (NMIBC) patients with intermediate/emergency level of priority, penile and testicular cancer patients, and upper tract urothelial cell carcinoma (UTUC) and renal cell carcinoma (RCC) patients with intermediate level of priority. Low applicability was observed for NMIBC patients with low/high level of priority, UTUC patients with high level of priority, prostate cancer patients with intermediate/high level of priority, and RCC patients with low level of priority. Conclusions During COVID-19, we found a reduction in all urologic activities. High-priority surgeries and timing of treatment recommended by the authorities require adaptation according to hospital resources and local incidence. Patient summary We assessed the urologic surgeries that were privileged during the first wave of coronavirus disease 2019 (COVID-19) in the three largest public hospitals in Lombardy, worst hit by the pandemic, to evaluate whether high-priority surgeries and timing of treatment recommended by the authorities are applicable. Pandemic recommendations provided by experts should be tailored according to hospital capacity and different levels of the pandemic.

At the end of the 21st century, we have been facing a second wave of an international public health emergency, a respiratory disease (coronavirus disease 2019 ) caused by a novel coronavirus (severe acute respiratory syndrome coronavirus 2[SARS-CoV-2]) [1, 2] . As of November 14, 2020, a total of 53 164 803 confirmed cases and 1 300 576 confirmed deaths in 220 countries were recorded, according to the World Health Organization (WHO) data [3] . Since its outbreak in December 2019 in China [4] , COVID-19 has spread rapidly all around the world, seeing

Italy as the first European country to be hit by the virus and one of the most affected countries [5, 6] . The first case of COVID-19 in Italy was reported on February 21, 2020, in the Lombardy region, which since then has always been on top of the ranking also J o u r n a l P r e -p r o o f during the second wave, with 1 144 552 confirmed cases and 44 683 deaths as of November 14, 2020 [7,8] . Milan, Brescia, and Bergamo have reported the highest number of cases since the beginning of this outbreak [7, 8] . Some authors reported their experience and the dramatic changes caused by COVID-19 in the management of urologic activities [9] [10] [11] [12] [13] [14] . However, the majority of these reports are qualitative studies that did not quantify the impact of this emergency on urologic activities [9, 14] or exclusively focused on the reduction of one urologic activity (ie, surgery or urologic emergencies) during the early phase of COVID-19 emergency [10] [11] [12] [13] , combining data of several European centres with different local capacities and different local incidences [11] . Therefore, a clear overview of the repercussions of SARS-CoV-2 on urologic practice is lacking. Moreover, it became challenging to identify which uro-oncologic patients required nondeferrable management in order to avoid delaying life-saving treatments [9] . During the first wave, several authorities [15] [16] [17] , including urologic guidelines [18] , redefined treatment options and timing of urologic surgical activities with the purpose of reorganising urologic practice during the COVID-19 pandemic. The first recommendations were published by Stensland et al [15] 

The Second, a join-point regression model was used to identify statistically significant changes in trends for each urologic activity over time [19, 20] . Average weekly percentage change (AWPC) and 95% confidence intervals (95% CIs) were estimated to summarise linear trends during the time frame assessed. Third, weekly urologic activities were temporally correlated with the weekly incidence and mortality of COVID-19 in Lombardy relying on the Pearson correlation method. COVID-19 epidemiology data on incidence and mortality were obtained from the Italian Ministry of Health [8] . Fourth, we assessed the "lag time" between the first COVID-19 case in Lombardy (February 21), the WHO public declaration of emergency (January 30), the Italian declaration of lockdown (March 9), and the reduction/blockage of the urologic activities by the government of Lombardy. Fifth, we assessed which urologic surgeries were privileged from February 21 to April 28, 2020, to evaluate whether high-priority surgeries and timing of treatment recommended by the authorities [15, 18] 

During 2019, the weekly amount of urologic surgeries (AWPC -0.3; 95% CI - A lag time analysis revealed a sharp decrease of urologic surgeries ( Fig. 1A -C), urologic consultations (Fig. 1F) , admissions for urologic diseases (Fig. 1G) , and urologic consultations requested by the central ED (Fig. 1H ) since the first COVID-19 case in

Italy from week 8. Conversely, a delay of 1 wk was observed for a reduction of diagnostic procedures (ie, cystoscopies and prostate biopsies; Fig. 1D and 1E ). Moreover, a lag time analysis revealed that the initial reduction of urologic activities was observed >3 wk after WHO public declaration of emergency ( Fig. 1 ) and that the Italian lockdown was declared on March 9, when all urologic activities were reduced by >50% (Fig. 1 ). diagnosis/treatment of urologic diseases [12] . A further possible explanation could be the reluctance to turn to ED service for the fear of being infected, despite the urgency for urologic consultation [23] . A decrease during the upswing in the pandemic phase was also observed for emergency surgeries. However, as expected, this was nonstatistically significant, suggesting that emergency surgeries cannot be postponed because of their gravity even during pandemic time. Overall, this general decrease of the urologic activities translates into missed/delayed diagnoses of urologic diseases, deferral treatment of many urologic malignancies, and less intensive oncologic follow-up of genitourinary cancer patients [24] . The consequences of this unprecedented health care scenario are premature to estimate, and future data will be produced in coming years that analyse the impact of diagnosis and treatment delays, and deintensification of follow-up on urologic outcomes. It might end in a higher number of patients being diagnosed with advanced urologic diseases and an increased cancer-specific mortality rate, especially for more aggressive cancers [24] . At the same time, it might be possible that a significant treatment delay of selected early-stage cancers or less intensive follow-up protocols will not impact long-term outcomes adversely, providing evidence to update current urologic guidelines.

To partially limit the consequences of this massive breakdown, since the middle/end of March (weeks 12-13; Fig. 1 ) when the incidence and mortality for COVID-19 in Lombardy reached the peak, a changing tendency was observed: a slow, constant reopening of all urologic activities was observed in all three centres involved in the "red J o u r n a l P r e -p r o o f area". Unfortunately, nowadays we are facing the second wave of this pandemic, reshaping again the health systems in several countries worldwide. It seems remote that medical practice will return to pre-COVID-19 patterns in the near future. Therefore, it becomes imperative to adapt and modify our urologic practice. In this regard, in order to reduce in-person interactions and the consequent risk of contagion, an increasing interest has been observed for the application of telemedicine to provide urologic care [25, 26] .

Evidence suggested that telemedicine has been implanted successfully in several urologic conditions [26] , making it appealing also after the end of this emergency.

Second, we observed a prompt reply in the reduction of urologic activities by

Lombardy region relative to the first COVID-19 case in Italy, except for diagnostic procedures (ie, cystoscopies and prostate biopsies), which started to show a drop-off 1 wk later. Notably, the WHO public declaration of emergency did not influence the reduction of all urologic activities, and the Italian declaration of lockdown arrived when the urologic practice had already been reduced overwhelmingly (Fig. 1) . Overall, these findings suggest a time gap between the onset of the emergency and the central government decisions. Nevertheless, it has to be acknowledged that the Italian government has been the first among the western countries to face the decision of a national lockdown.

Third, when we assessed the uro-oncologic surgeries performed from February 21, 2020 to April 28, 2020, we observed that 70% were high-priority surgeries according to the recommendations by Stensland et al [15] . Notably, 30% of these surgeries were treatments that could have been postponed according to the expert recommendations ( (Table 2) , were expected, considering the single department case mix and bearing in mind that typically urologic departments fight to treat uro-oncologic patients within the deadline (ie, 30 d) proposed by regional guidelines outside the COVID-19 era [9] . The findings observed might be explained by the fact that urologists had to struggle with a new scenario: reorganise the operating rooms (ORs) according to urologically prioritised malignancies [24] , reduced number of accessible ORs, available health care staff, and number of elective vacant urologic and intensive care unit beds [22] , and move to COVID-free structures to treat urologic patients and patients who refused to receive any kind of treatment during the COVID-19 period. Overall, these results suggest that urologic pandemic recommendations provided by experts [15, 18] 

All urologic activities in the three largest public hospitals in Lombardy, worst hit by the pandemic, underwent a considerable reduction throughout the COVID-19 pandemic J o u r n a l P r e -p r o o f

High-risk PCa RP + ePLND 9 (3.9) High-risk (locally advanced) PCa RP + ePLND 12 (5.2) ePLND = extended pelvic lymph node dissection; IVC = inferior vena cava; PCa = prostate cancer; PN = partial nephrectomy; RC = radical cystectomy; RN = radical nephrectomy; RNU = radical nephroureterectomy; RP = radical prostatectomy; TURBT = transurethral resection of bladder tumour; UTUC = upper tract urothelial cell carcinoma. a cT1 renal masses should be delayed or other forms of ablative approaches should be considered; cT2 renal masses should be considered for delay based upon patient-specific considerations, such as age, morbidity, symptoms, and tumour growth rate. Most prostatectomies should be delayed. If high-risk PCa patients are ineligible for radiation therapy, radical prostatectomy should be considered.

J o u r n a l P r e -p r o o f Table 2 -Uro-oncologic surgeries performed in the three largest public hospitals in Lombardy located in the most affected area in Italy (Brescia, Bergamo, and Milan) from February 21 to April 28, 2020, stratified according to the level of priority and timing of surgery defined by EAU guidelines during the COVID-19 pandemic [18] 

A novel coronavirus outbreak of global health concern

COVID-19 and urology: a comprehensive review of the literature

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

COVID-19 and Italy: what next?

Coronavirus disease 2019 (COVID-19) in Italy

Urology in the time of corona

Surgical volume, safety, drug administration, and clinical trials during COVID-19: single-center

The impact of COVID-19 outbreak on urooncological practice across Europe: which burden of activity are we facing ahead?

The impact of COVID-19 pandemic on urological emergencies: a single-center experience

Impact of the COVID-19 pandemic on urological practice in emergency departments in Italy

A global survey on the impact of COVID-19 on urological services

Considerations in the triage of urologic surgeries during the COVID-19 pandemic

Urology practice during COVID-19 pandemic

EAU Robotic Urology Section (ERUS) guidelines during COVID-19

European Association of Urology Guidelines Office Rapid Reaction Group: an organisation-wide collaborative effort to adapt the European Association of Urology guidelines recommendations to the coronavirus disease 2019 era

Permutation tests for joinpoint regression with applications to cancer rates

Consulting "Dr. Google" for prostate cancer treatment options: a contemporary worldwide trend analysis

Coronavirus, i rischi per gli operatori sanitari

Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response

Pathways for urology patients during the COVID-19 pandemic

Risks from deferring treatment for genitourinary cancers: a collaborative review to aid triage and management during the COVID-19 pandemic

The impact of the COVID-19 pandemic on genitourinary cancer care: re-envisioning the future

Telehealth in urology: a systematic review of the literature. How much can telemedicine be useful during and after the COVID-19 pandemic

Type of surgery performed Levels of priority according to EAU guidelines during COVID-19 pandemic, % (n/N)